These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30520829)

  • 41. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?
    Lodise TP; Drusano GL; Zasowski E; Dihmess A; Lazariu V; Cosler L; McNutt LA
    Clin Infect Dis; 2014 Sep; 59(5):666-75. PubMed ID: 24867791
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant
    Stoessel AM; Hale CM; Seabury RW; Miller CD; Steele JM
    J Pharm Pract; 2019 Aug; 32(4):442-446. PubMed ID: 29554847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    Sorrell TC; Packham DR; Shanker S; Foldes M; Munro R
    Ann Intern Med; 1982 Sep; 97(3):344-50. PubMed ID: 7114631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).
    Gould IM
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S17-21. PubMed ID: 23664580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on Outcome.
    McNeil JC; Kok EY; Forbes AR; Lamberth L; Hulten KG; Vallejo JG; Mason EO; Kaplan SL
    Pediatr Infect Dis J; 2016 Mar; 35(3):263-8. PubMed ID: 26646549
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relationships between vancomycin minimum inhibitory concentration, dosing strategies, and outcomes in methicillin-resistant Staphylococcus aureus bacteremia.
    Clemens EC; Chan JD; Lynch JB; Dellit TH
    Diagn Microbiol Infect Dis; 2011 Dec; 71(4):408-14. PubMed ID: 21924852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
    Ruiz-Ramos J; Vidal-Cortés P; Díaz-Lamas A; Reig-Valero R; Roche-Campo F; Del Valle-Ortiz M; Nuvials-Casals X; Ortiz-Piquer M; Andaluz-Ojeda D; Tamayo-Lomas L; Blasco-Navalpotro MA; Rodriguez-Aguirregabiria M; Aguado J; Ramirez P
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1569-1575. PubMed ID: 28378244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
    Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis.
    Diaz R; Afreixo V; Ramalheira E; Rodrigues C; Gago B
    Clin Microbiol Infect; 2018 Feb; 24(2):97-104. PubMed ID: 28648858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.
    Moise-Broder PA; Forrest A; Birmingham MC; Schentag JJ
    Clin Pharmacokinet; 2004; 43(13):925-42. PubMed ID: 15509186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant staphylococcus aureus pneumonia.
    Suzuki Y; Kawasaki K; Sato Y; Tokimatsu I; Itoh H; Hiramatsu K; Takeyama M; Kadota J
    Chemotherapy; 2012; 58(4):308-12. PubMed ID: 23147106
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different formulations of vancomycin: In vitro antimicrobial activity against clinical isolates of methicillin-resistant Staphylococcus aureus.
    Fabri FV; Lolis MA; Gimenes M; Tognim MCB; Caparroz-Assef SM
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):332-337. PubMed ID: 30033164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vancomycin minimum inhibitory concentration and outcome in patients with Staphylococcus aureus bacteremia: pearl or pellet?
    Holland TL; Fowler VG
    J Infect Dis; 2011 Aug; 204(3):329-31. PubMed ID: 21742827
    [No Abstract]   [Full Text] [Related]  

  • 55. Correlation of a Vancomycin Pharmacokinetic Model and Trough Serum Concentrations in Pediatric Patients.
    Ploessl C; White C; Manasco K
    Pediatr Infect Dis J; 2015 Oct; 34(10):e244-7. PubMed ID: 26121203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The dosing and monitoring of vancomycin: what is the best way forward?
    Drennan PG; Begg EJ; Gardiner SJ; Kirkpatrick CMJ; Chambers ST
    Int J Antimicrob Agents; 2019 Apr; 53(4):401-407. PubMed ID: 30599240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.
    Holmes NE; Turnidge JD; Munckhof WJ; Robinson JO; Korman TM; O'Sullivan MV; Anderson TL; Roberts SA; Gao W; Christiansen KJ; Coombs GW; Johnson PD; Howden BP
    J Infect Dis; 2011 Aug; 204(3):340-7. PubMed ID: 21742831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inadequate vancomycin therapy in term and preterm neonates: a retrospective analysis of trough serum concentrations in relation to minimal inhibitory concentrations.
    Sinkeler FS; de Haan TR; Hodiamont CJ; Bijleveld YA; Pajkrt D; Mathôt RA
    BMC Pediatr; 2014 Jul; 14():193. PubMed ID: 25066951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Optimal vancomycin serum level in Staphylococcus aureus infections?].
    Bingen E; Mariani-Kurkdjian P; Nebbad B
    Med Mal Infect; 2006 Sep; 36(9):439-42. PubMed ID: 17027219
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.